Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
Drug Discovery
Intellectual Property
R&D Pipeline
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

Cobroxin for Chronic Pain

Cobroxin is the first over-the-counter pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. The drug will be available as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia and as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis.

For additional information about Cobroxin, visit

Quick Nav
Nyloxin // Chronic Pain Relief
Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.


Recent News
September 14, 2016
Nutra Pharma Announces Manufacturing Alliance with Omnia Biologics to Produce RPI-78M for Clinical Trials in Pediatric Multiple Sclerosis

August 30, 2016
Nutra Pharma Announces Addition of Maj. Gen. Kenneth Dowd to its Advisory Board

August 16, 2016
Nutra Pharma Announces Additions to the Board of Directors and Management Team

Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
Facebook   Twitter
Privacy Policy Code of Ethics